News & Press: Breaking News

Survey of Cellular and Engineered Tissue Therapies in Europe - Patients Treated in 2013

Monday, May 26, 2014  
Posted by: ISCT Administrator
Share |

Dear colleagues


We are collecting data in order to establish a comprehensive, quantitative map of patients being treated in Europe with cellular and engineered tissue therapies (i.e. any clinical treatment based on living cells excluding DLI, donor lymphocyte infusions, and hematopoietic stem cells for hematological reconstitution). The survey is supported by the 5 international organisations shown above and integrates the original EBMT activity survey capturing hematopoietic stem cells transplants in Europe.


Attached is a file of the survey reports published in the past 5 years, together with an overview of the unpublished data for patients treated in 2012. The overview, which contains unpublished data, is for personal use only. The report includes the number of treated patients, without any reference to clinical outcomes, information on specific cell types, processes and delivery modes in use as well as an appendix listing active teams.


If, in 2013, you treated patients in Europe with cellular or engineered tissue therapies and would like to see your name listed among the participating teams (138 groups in 2012), please complete the enclosed survey form and send it by August 31st 2014 to Helen Baldomero in the Activity Survey Office, either by Email: or by fax: + 41 61 265 2735


If you know of any group that is performing such therapies please forward this message to them and encourage them to participate. This will help to bring an effective impact on the scientific, clinical and regulatory aspects of the quickly evolving sector of cellular and engineered tissue therapies.


Thank you and with our best regards                                                              



Prof. Ivan Martin PhD

Depts. of Surgery and Biomedicine

University Hospital Basel, CH


Prof. Jakob R Passweg MD
Chief Hematology Clinic and
EBMT Transplant Activity Survey Office

University Hospital Basel, CH

Survey on Cellular and Engineered Tissue Therapies in Europe 2008-2011
Letter to Members re Survey for 2013 Patients
Guidelines for the Cellular and Engineered Tissue Therapy Survey 2013
Cellular and Engineered Tissue Therapies Survey 2013

© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.